This is a proposal for continuation of a Program project Grant to study both fundamental and clinical aspects of coagulation, focusing especially on fibrinogen, fibrin and fibrinolytic therapy. The long-term objectives are to better understand fundamental questions and to translate this information from the laboratory to the bedside in order to improve the diagnosis and management of thrombotic disease.
Specific aims of basic studies are to elucidate the structure/function relationship of fibrinogen and the macromolecular organization of the alpha-polymer in crosslinked fibrin and its plasmic derivatives, the mechanisms and consequences of fibrin interaction with endothelial cells, the interaction of fibrinogen with thrombin and dynamic evolution into a fibrin polymer following this interaction, the identification of functional domains of a recombinant hybrid prethrombin/trypsin enzyme, the expression of fibrinogen in megakaryocytes and hepatocytes and the mechanisms of its genetic control, especially regrading the synthesis of variants of the fibrinogen gamma chain, the effects of soluble fibrin polymers on blood viscosity and the physical structure of thrombi as defined by magnetic resonance imaging. Clinical studies will compare new thrombolytic agents and regimens in coronary artery syndromes and in deep vein thrombosis, test new prophylactic approaches for preventing deep vein thrombosis after orthopedic procedures, assess the diagnostic potential of magnetic resonance imaging for evolving thrombi, and apply changes in blood parameters of fibrinogen and fibrinolysis and a new assay under development) for unique alpha-polymer degradation products as related to clinical events of vascular occlusion, vascular reperfusion and bleeding, The five research projects will be supported by three Core facilities, devoted to administration, tissue culture and monoclonal antibody production and clinical services related to patient observations, coagulation assays and data analysis. In addition to a primary goal of new fundamental observations made by scientists working individually and in concert, the program emphasizes a balance between the expertise of fundamental and clinical scientists working independently and in concert with each other, and in the bidirectional flow of ideas and data between the laboratory bench and the hospital bed.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
5P01HL030616-09
Application #
3098211
Study Section
Heart, Lung, and Blood Research Review Committee B (HLBB)
Project Start
1983-07-01
Project End
1993-06-30
Budget Start
1991-08-23
Budget End
1992-06-30
Support Year
9
Fiscal Year
1991
Total Cost
Indirect Cost
Name
University of Rochester
Department
Type
Schools of Dentistry
DUNS #
208469486
City
Rochester
State
NY
Country
United States
Zip Code
14627
Sahni, Sanjeev K; Rydkina, Elena (2009) Host-cell interactions with pathogenic Rickettsia species. Future Microbiol 4:323-39
Sahni, Abha; Arévalo, Maria T; Sahni, Sanjeev K et al. (2009) The VE-cadherin binding domain of fibrinogen induces endothelial barrier permeability and enhances transendothelial migration of malignant breast epithelial cells. Int J Cancer 125:577-84
Sahni, Sanjeev K; Rydkina, Elena; Sahni, Abha (2008) The proteasome inhibitor MG132 induces nuclear translocation of erythroid transcription factor Nrf2 and cyclooxygenase-2 expression in human vascular endothelial cells. Thromb Res 122:820-5
Sahni, A; Simpson-Haidaris, P J; Sahni, S K et al. (2008) Fibrinogen synthesized by cancer cells augments the proliferative effect of fibroblast growth factor-2 (FGF-2). J Thromb Haemost 6:176-83
Mosesson, M W; Hernandez, I; Raife, T J et al. (2007) Plasma fibrinogen gamma'chain content in the thrombotic microangiopathy syndrome. J Thromb Haemost 5:62-9
Rydkina, Elena; Sahni, Abha; Baggs, Raymond B et al. (2006) Infection of human endothelial cells with spotted Fever group rickettsiae stimulates cyclooxygenase 2 expression and release of vasoactive prostaglandins. Infect Immun 74:5067-74
Sahni, Abha; Khorana, Alok A; Baggs, Raymond B et al. (2006) FGF-2 binding to fibrin(ogen) is required for augmented angiogenesis. Blood 107:126-31
Duan, Hai Ou; Simpson-Haidaris, Patricia J (2006) Cell type-specific differential induction of the human gamma-fibrinogen promoter by interleukin-6. J Biol Chem 281:12451-7
Fay, Philip J; Jenkins, P Vincent (2005) Mutating factor VIII: lessons from structure to function. Blood Rev 19:15-27
Clifton, Dawn R; Rydkina, Elena; Huyck, Heidie et al. (2005) Expression and secretion of chemotactic cytokines IL-8 and MCP-1 by human endothelial cells after Rickettsia rickettsii infection: regulation by nuclear transcription factor NF-kappaB. Int J Med Microbiol 295:267-78

Showing the most recent 10 out of 268 publications